Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meryl Brod

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Depression and Anxiety|March 17, 2004
Cross-sectional 7-year follow-up of anxiety in primary care patientsShoshana S Colman, Meryl Brod, Lori P Potter, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2021
Letter to the Editor From Sävendahl et al.: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"Lars Sävendahl, Tadej Battelino, Meryl Brod, et al.
Current Medical Research and Opinion|June 7, 2016
Perceptions of diabetes control among people with type 2 diabetes treated with basal insulin in Sweden, Switzerland, and the United KingdomMeryl Brod, Kathryn M Pfeiffer, Anthony H Barnett, et al.
Journal of Patient-Reported Outcomes|May 15, 2018
Development of the Weight-Related Sign and Symptom MeasureMeryl Brod, Lise Højbjerre, Kathryn M Pfeiffer, et al.
Journal of Medical Economics|July 26, 2014
The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveysGregory Fulcher, Joelle Singer, Rutila Castañeda, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2023
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3Lars Sävendahl, Tadej Battelino, Michael Højby Rasmussen, et al.
The Patient|April 8, 2017
Understanding Treatment Burden for Children Treated for Growth Hormone DeficiencyMeryl Brod, Lise Højbjerre, Suzanne Lessard Alolga, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 2, 2017
Understanding burden of illness for child growth hormone deficiencyMeryl Brod, Suzanne Lessard Alolga, Jane F Beck, et al.
Pharmacoeconomics - Open|January 12, 2021
Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)Meryl Brod, Michael Højby Rasmussen, Knud Vad, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2020
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 TrialLars Sävendahl, Tadej Battelino, Meryl Brod, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Depression and Anxiety|March 17, 2004
Cross-sectional 7-year follow-up of anxiety in primary care patientsShoshana S Colman, Meryl Brod, Lori P Potter, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2021
Letter to the Editor From Sävendahl et al.: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"Lars Sävendahl, Tadej Battelino, Meryl Brod, et al.
Current Medical Research and Opinion|June 7, 2016
Perceptions of diabetes control among people with type 2 diabetes treated with basal insulin in Sweden, Switzerland, and the United KingdomMeryl Brod, Kathryn M Pfeiffer, Anthony H Barnett, et al.
Journal of Patient-Reported Outcomes|May 15, 2018
Development of the Weight-Related Sign and Symptom MeasureMeryl Brod, Lise Højbjerre, Kathryn M Pfeiffer, et al.
Journal of Medical Economics|July 26, 2014
The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveysGregory Fulcher, Joelle Singer, Rutila Castañeda, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2023
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3Lars Sävendahl, Tadej Battelino, Michael Højby Rasmussen, et al.
The Patient|April 8, 2017
Understanding Treatment Burden for Children Treated for Growth Hormone DeficiencyMeryl Brod, Lise Højbjerre, Suzanne Lessard Alolga, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 2, 2017
Understanding burden of illness for child growth hormone deficiencyMeryl Brod, Suzanne Lessard Alolga, Jane F Beck, et al.
Pharmacoeconomics - Open|January 12, 2021
Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)Meryl Brod, Michael Højby Rasmussen, Knud Vad, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2020
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 TrialLars Sävendahl, Tadej Battelino, Meryl Brod, et al.
Pageof 9